[Morphazinamide--clinical tolerance and side effects].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000995:Antitubercular Agents / Q000627:therapeutic use*; D005000:Ethionamide / Q000627:therapeutic use; D005260:Female; D005767:Gastrointestinal Diseases / Q000150:complications*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011718:Pyrazinamide / Q000627:therapeutic use; D011719:Pyrazines / Q000009:adverse effects / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D011719:Pyrazines; D011718:Pyrazinamide; D005000:Ethionamide
Morfazinamid--tolerancja kliniczna i działanie uboczne.